Imbio PHA (4.0.0) vs KardiaPro
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if your practice requires rapid, automated analysis of CT pulmonary angiogram (CTPA) scans to assess right ventricular dilation. This tool is ideal for aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension, providing crucial measurements and ratios (like RV/LV and PA/Ao) to inform acute care decisions. It integrates seamlessly into existing DICOM workflows, delivering annotated images and summary reports quickly.
View Imbio PHA (4.0.0) →Choose KardiaPro if…
Choose KardiaPro if you need a comprehensive, web-based platform for remote patient monitoring of ECG, blood pressure, and weight data. This tool is best suited for managing and reviewing patient cardiac data between appointments, especially for detecting arrhythmias and tracking longitudinal cardiac patterns. It integrates with personal ECG devices like KardiaMobile, allowing for efficient data review and informed clinical decision-making for patients with conditions like atrial fibrillation.
View KardiaPro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | KardiaPro |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud, Enterprise (on-premise), or via partners | Cloud-hosted, Web-based |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
KardiaProKardiaPro offers a comprehensive web-based portal for remote monitoring, including a customizable ECG inbox and automated summary reports, which suggests a user-friendly interface for healthcare professionals managing patient data. Imbio PHA, while automated and integrated into existing PACS workflows, focuses more on image processing and report generation rather than an interactive portal for ongoing patient management.
Clinical Value
KardiaProKardiaPro provides FDA-cleared AI for arrhythmia detection and comprehensive remote monitoring of ECG, blood pressure, and weight data, enabling continuous patient care and early identification of issues. Imbio PHA focuses on automated measurements from CT scans for risk stratification in pulmonary embolism and hypertension, which is valuable but more specialized and less continuous than KardiaPro's monitoring capabilities.
Pricing & Value
TieBoth tools require contacting the company for pricing information, making direct comparison difficult. However, KardiaPro mentions that it is reimbursable using existing CPT codes, which can add significant value for healthcare providers.
Enterprise Readiness
Imbio PHA (4.0.0)Imbio PHA offers flexible deployment options including Cloud, Enterprise (on-premise), or via partners, and emphasizes seamless integration with native DICOM tools and workflows, indicating strong enterprise readiness. KardiaPro is cloud-hosted and web-based, with integration capabilities, but Imbio's explicit on-premise option and focus on DICOM workflow integration suggest a broader approach to enterprise environments.
Innovation
TieBoth tools demonstrate innovation in their respective domains. Imbio PHA utilizes AI for automated, rapid analysis of cardiac structures from CT scans, transforming medical images into insights. KardiaPro offers FDA-cleared AI for arrhythmia detection within a comprehensive remote patient monitoring platform, integrating wearables and providing continuous data analysis.
Support & Docs
TieNeither the provided JSON nor the web search results offer specific details about the depth or accessibility of support and documentation for either product. Therefore, it is not possible to definitively pick a winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | KardiaPro |
|---|---|---|
| Name | Imbio PHA (4.0.0) | KardiaPro |
| Company | Imbio | AliveCor |
| Description | FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | Comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations. |
| Primary Use Case | Automated measurement of cardiac structures from CTPA scans for pulmonary embolism and hypertension assessment. | Remote monitoring of patient ECG, blood pressure, and weight data with AI for arrhythmia detection. |
| Key Features (Examples) | Automated measurement of right and left ventricle diameters; Generates annotated DICOM images; Provides summary reports in PDF format. | ECG, blood pressure, and weight data management; FDA-cleared AI for arrhythmia detection; Automated summary reports and trend visualization. |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and KardiaPro.
Frequently Asked Questions
More Comparisons
More matchups featuring Imbio PHA (4.0.0) or KardiaPro
Backers
Who funded each tool's parent company.